BioWorld. Link to homepage.

Clarivate
  • BioWorld
  • BioWorld Science
  • BioWorld Asia
  • Data Snapshots
    • Biopharma
    • Medical technology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • NME Digest
  • Special reports
    • Infographics: Dynamic digital data analysis
    • Trump administration impacts
    • Med-tech outlook 2026
    • Under threat: mRNA vaccine research
    • BioWorld at 35
    • Biopharma M&A scorecard
    • Bioworld 2025 review
    • BioWorld MedTech 2025 review
    • BioWorld Science 2025 review
    • Women's health
    • China's GLP-1 landscape
    • PFA re-energizes afib market
    • China CAR T
    • Alzheimer's disease
    • Coronavirus
    • More reports can be found here

BioWorld. Link to homepage.

  • Sign In
  • Sign Out
  • My Account
Subscribe
BioWorld - Saturday, May 2, 2026
Home » Authors » John Brosky

John Brosky

Articles

ARTICLES

U.K. outlook declines as uncertainty increases with dawdling Brexit

July 20, 2016
By John Brosky

Integragen to build out genomic sequencing network for 38 hospitals

July 13, 2016
By John Brosky

France investing $742M to accelerate clinical genomic sequencing

July 12, 2016
By John Brosky

Countdown begins for conforming to new, more stringent EU regulations

July 7, 2016
By John Brosky
PARIS – It is hardly a thriller, but there are 700 pages to add to your summer reading that will give you chills sitting on the beach if your company is currently selling medical devices in the European Union, or if it plans to do so anytime soon.
Read More

EU grant accelerates U.K. startup in bid to join the liquid biopsy gold rush

June 29, 2016
By John Brosky

FDA approval gives Medicrea traction for patient-specific spine implants

June 24, 2016
By John Brosky

Microsoft deal opens up door for Median's cancer cloud computing software

June 23, 2016
By John Brosky

EU reaches accord on stricter regulations for medtech, IVDs

May 31, 2016
By John Brosky
PARIS — The European Union reached agreement on the reform of regulations for the CE mark that governs the commercialization of medical devices and in vitro diagnostic tests (IVDs) in the world's second-largest market.
Read More

Mega-mergers in CV help to pump up product portfolios, expand footprints

May 23, 2016
By John Brosky
PARIS – The wave of mergers and acquisitions in medical technologies that is reshaping the industry could be seen in the shuffling of brand names on the exhibition floor at EuroPCR, the largest European meeting for interventional cardiologists.
Read More

Breakthrough techniques tap software to reveal causes of cardiac disease

May 20, 2016
By John Brosky
PARIS – "If we can measure it, we can manage it" would have made a better title than "Imaging and Functional Assessment" for a session at EuroPCR 2016 presenting new techniques for cardiovascular diagnostics.
Read More
View All Articles by John Brosky

Popular Stories

  • News in brief

    BioWorld Asia
    BioWorld Asia briefs for April 28, 2026
  • AI generated image for researcher developing antisense oligonucleotides

    Bio Korea 2026 kicks off with spotlight on oligonucleotides

    BioWorld
    Three decades of trial-and-error, and the resulting safety data, in the oligonucleotide-based therapeutic space have paved way for the present-day innovations and...
  • Chinabio 2026 partnering

    Chinese biotechs gain leverage as partners in dealmaking

    BioWorld
    China’s biotech ecosystem has crossed an inflection point, and Chinese biotechs are gaining leverage in dealmaking, executives from multinational companies said...
  • University of Western Australia patents 5-HT2A/B modulators

    BioWorld Science
    University of Western Australia has identified new lysergic acid diethylamide (LSD) analogues acting as 5-HT2A and 5-HT2B modulators reported to be useful for the...
  • Neurons

    AA meeting of minds as PTC, Novartis push votoplam in HD

    BioWorld
    What PTC Therapeutics Inc.’s latest data with votoplam might mean in the Huntington’s disease (HD) landscape became grist for Wall Street after the firm unveiled...
  • BioWorld
    • Today's news
    • Analysis and data insight
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Medical technology
    • Newco news
    • Opinion
    • Regulatory
  • BioWorld Science
    • Today's news
    • Biomarkers
    • Cancer
    • Conferences
    • Endocrine/metabolic
    • Immune
    • Infection
    • Neurology/psychiatric
    • NME Digest
    • Patents
  • BioWorld Asia
    • Today's news
    • Analysis and data insight
    • Australia
    • China
    • Clinical
    • Deals and M&A
    • Financings
    • Newco news
    • Regulatory
    • Science
  • More
    • About
    • Advertise with BioWorld
    • Archives
    • Article reprints and permissions
    • Contact us
    • Cookie policy
    • Copyright notice
    • Data methodology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • Podcasts
    • Privacy policy
    • Share your news with BioWorld
    • Staff
    • Terms of use
    • Topic alerts
Follow Us

Copyright ©2026. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing